The Cardiovascular Device Clinical Trials Collaborative Project
In Australia and around the world, cardiovascular disease kills 17.5 million people every year, with one Australian dying from cardiovascular disease every 12 minutes.
The Cardiovascular Device Clinical Trial Collaborative Project is an ACvA-led consortium from across the ACvA national membership with funding from leading industry partners including The Charles Perkins Centre - The University of Sydney and the Victor Chang Cardiac Research Institute.
The Project will, for the first time, map the capabilities and resources specifically available to support cardiovascular medtech development in Australia. By creating an online searchable portal, the project will improve collaboration and promote the development of medical devices for cardiovascular disease in Australia.
The Project will also develop a clinical trial service to support research groups locally and internationally to set up cardiovascular-related clinical trials for medical devices in Australia. This service hopes to increase the number of Australian patients receiving life-saving treatment for their cardiovascular conditions.
Outcomes: The accessible, searchable portal of the cardiovascular clinical trial and testing sector has been developed and is being tested. The consortium are in discussions with companies regarding test cardiovascular projects to refine the service offerings and identify any additional gaps
|State||New South Wales|
|Consortium Lead||Australian Cardiovascular Alliance|
|Consortium Members||The Charles Perkins Centre - The University of Sydney & Victor Chang Cardiac Research Institute|
|Project Duration||February 2021 - February 2022|
|Contact||Kerry Doyle, Executive Director ACvA|
Visit the Australian Cardiovascular Alliance for more information.
Twitter: @OzCvA | LinkedIn: Australian Cardiovascular Alliance
 Heart Disease, Victor Chang Cardiac Research Institute. Retrieved on 9 February 2021. https://www.victorchang.edu.au/heartdisease